Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1802-1811

  Tashkin, Donald P ^a   Altose, Murray D ^a   Connett, John E ^a   Kanner, Richard E ^a   Lee, Wondra W ^a   Wise, Robert A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IPRATROPIUM BROMIDE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 0029936262     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665038     Document Type: Article

References (39)

1. Orie, N. G. M., H. J. Sluiter, K. de Vries, G. J. Tammeling, and J. Witkop. 1961. The host factor in bronchitis. In N. G. M. Orie and H. J. Sluiter, editors. Bronchitis, an International Royal Symposium. Royan Van Gorcum, Assen, The Netherlands. 43-59.
2. Barter, C. E., and A. H. Campbell. 1976. Relationship of constitutional factors and cigarette smoking to decrease in 1-second forced expiratory volume. Am. Rev. Respir. Dis. 113:305-314.
3. Campbell, A. H., C. E. Barter, J. M. O'Connell, and R. Huggins. 1985. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax 40:741-748.
4. Kanner, R. E. 1984. The relationship between airways responsiveness and chronic airflow limitation. Chest 86:54-57.
5. Tabona, M., M. Chan-Yeung, D. Enarson, L. MacLean, E. Dorken, and M. Schulzer. 1984. Host factors affecting longitudinal decline in lung spirometry among grain elevator workers. Chest 85:782-786.
6. 1 in male smokers and exsmokers. Thorax 40:9-16.
7. Vollmer, W. M., L. R. Johnson, and A. S. Buist. 1985. Relationship of response to a bronchodilator and decline in forced expiratory volume in one second in population studies. Am. Rev. Respir. Dis. 132:1186-1193.
8. Sparrow, D., G. O'Connor, and S. T. Weiss. 1988. The relation of airway responsiveness and atopy to the development of chronic obstructive lung disease. Epidemiol. Rev. 10:29-47.
9. Pride, N. B. 1988. Bronchial hyperreactivity in smokers. In D. Hughes, editor. Weisbaden Symposium: The Clinical Significance of Bronchial Hyperreactivity. SEPCR Symposium. Eur. Respir. J. 1:485-487.
10. Freedman, B. J. 1972. The functional geometry of the bronchi. Bull. Physiopathol. Respir. 8:545-551.
11. Moreno, R. H., J. C. Hogg, and P. D. Pare. 1986. Mechanics of airway narrowing. Am. Rev. Respir. Dis. 133:1171-1180.
12. 1. J.A.M.A. 272:1497-1505.
13. Tashkin, D. P., M. D. Altose, J. E. Connett, R. E. Kanner, W. W. Lee, R. Wise, for the Lung Health Study Research Group. 1992. Airway responsiveness to inhaled methacholine in smokers with early chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 145: 301-310.
14. Buist, A. S., J. E. Connett, R. D. Miller, R. E. Kanner, G. R. Owens, H. T. Voelker, and the Lung Health Study Research Group. 1993. Chronic obstructive pulmonary disease intervention trial. Baseline characteristics of randomized participants. Chest 103:1863-1872.
15. Ferris, B. G. 1978. Epidemiologic standardization project. Am. Rev. Respir. Dis. 118:(6, Part 2):1-88.
16. Crapo, R. D., A. H. Morris, and R. M. Gardner. 1981. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis. 123:659-664.
17. Chai, H., R. S. Farr, L. A. Froehlich, D. A. Mathison, J. A. McLean, R. R. Rosenthal, A. L. Scheffer, S. L. Spector, and R. G. Townley. 1975. Standardization of bronchial inhalation challenge procedures. J. Allergy Clin. Immunol. 56:323-327.
18. Enright, P. L., L. R. Johnson, J. E. Connett, H. Voelker, and A. S. Buist. 1991. Spirometry in the Lung Health Study. I: Methods and quality control. Am. Rev. Respir. Dis. 143:1215-1223.
19. O'Hara, P., J. Grill, M. A. Rigdon, J. E. Connett, G. A. Lauger, and J. J. Johnston. 1993. Design and results of the initial intervention program for the Lung Health Study. Prev. Med. 22:304-315.
20. Laird, N. M., and J. H. Ware. 1982. Random effects models for longitudinal data. Biometrics 38:963-974.
21. SAS. 1993. SAS/STAT User's Guide, Version 6, 4th ed. SAS Institute Inc., Cary, NC. 1993.
22. Kanner, R. E., M. D. Altose, J. E. Connett, D. P. Tashkin, R. Wise, and the Lung Health Study Research Group. 1994. Analysis of male: female prevalence differences in airway hyperresponsiveness in smokers with mild COPD in the Lung Health Study. Am. J. Respir. Crit. Care Med. 150:956-961.
23. 1. Am. J. Respir. Crit. Care Med. 151:1377-1382.
24. O'Connor, G. T., D. Sparrow, and S. T. Weiss. 1995. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary function decline: the Normative Aging Study. Am. J. Respir. Crit. Care Med. 152:87-92.
25. 1: a longitudinal study in the elderly. Am. J. Respir. Crit. Care Med. 151:656-662.
26. 1 decline in male working populations. Am. Rev. Respir. Dis. 148: 878-883.
27. Van der Lende, R., J. P. M. de Kroon, G. G. Van der Meulen, G. J. Tammeling, B. F. Visser, K. De Vries, and N. G. M. Orie. 1970. Possible indicators of endogenous factors in the development of CNSLD. In N. G. M. Orie and R. Van der Lende, editors. Bronchitis III. Royal Vangorcum, Assen, The Netherlands. 52-79.
28. Lim, T. K., R. G. Taylor, A. Watson, H. Joyce, and N. B. Pride. 1988. Changes in bronchial responsiveness to inhaled histamine over four years in middle aged male smokers and ex-smokers. Thorax 43: 599-604.
29. Enright, P. L., J. E. Connett, R. E. Kanner, L. F. Johnson, and W. W. Lee. 1995. Spirometry in the Lung Health Study: II. Determinants of short-term intraindividual variability. Am. J. Respir. Crit. Care Med. 151:406-411.
30. Anthonisen, N. R., E. C. Wright, and I. P. P. B. Trial Group. 1986. Bronchodilator response in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 133:814-819.
31. Postma, D. S., K. de Vries, G. H. Koeter, and H. J. Sluiter. 1986. Independent influence of reversibility of airflow obstruction and non-specific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am. Rev. Respir. Dis. 134:276-280.
32. Kanner, R. E., A. D. Renzetti, Jr., M. R. Klauber, C. B. Smith, and C. A. Golden. 1979. Variables as lociated with changes in spirometry in patients with obstructive lung diseases. Am. J. Med. 67:44-50.
33. Thompson, A. B., M. B. Mueller, A. J. Heires, et al. 1993. Aerosolized beclomethasone in chronic bronchitis. Am. Rev. Respir. Dis. 146: 389-395.
34. Kerstjens, H. A. M., P. L. P. Brand, M. D. Hughes, et al., and the Dutch Chronic Non-Specific Lung Disease Study Group. 1992. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N. Engl. J. Med. 327:1413-1419.
35. Rand, C. S., R. A. Wise, M. Nides, M. S. Simmons, E. R. Bleecker, J. W. Kusek, V. C. Li, and D. P. Tashkin. 1992. Inhaler adherence in a clinical trial: comparison of self-report and canister weighing to the nebulizer chronolog. Am. Rev. Respir. Dis. 146:1559-1564.
36. Nides, M. A., D. P. Tashkin, M. S. Simmons, R. A. Wise, V. C. Li, and C. S. Rand. 1993. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 104:501-507.
37. van Schyack, C. P., E. Dompeling, C. L. van Herwaarden, H. Folgering, A. L. Verbeek, H. J. van der Hoogen, and C. van Weel. 1991. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. B.M.J. 303:1426-1431.
38. Kerrebijn, K. F., E. E. M. van Essen-Zandvleit, and H. J. Neijens. 1987. Effects of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J. Allergy Clin. Immunol. 79:653-659.
39. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel group controlled trial. J. Allergy Clin. Immunol. 90:32-42.